Product Description
| Brand | Snibe |
| Sample Type | Serum |
| Pack Size | 50T |
| CAT No. | 130617504M |
| Application | Autoimmune |
The kit has been designed for the qualitative determination of extractable nuclear antigen (ENA) antibodies in human serum or plasma. The method can be used for samples within a measuring range of 0.1-10 COI. The test is performed on fully automated MAGLUMI chemiluminescence immunoassay (CLIA) analyzers, including MAGLUMI 800, MAGLUMI X8, and other MAGLUMI models such as MAGLUMI 1000, MAGLUMI 2000, MAGLUMI 2000 Plus, and MAGLUMI 4000.Advanced Autoimmune Screening SolutionMAGLUMI ENA Screen (CLIA) empowers laboratories to conduct highly sensitive and advanced autoimmune antibody testing. Its proprietary chemiluminescence immunoassay technology ensures swift and definitive detection of ENA antibodies, supporting accurate diagnosis. Compatible exclusively with MAGLUMI CLIA analyzers, it integrates seamlessly into standard laboratory workflows and boosts diagnostic efficiency in clinical settings.
Optimal Storage and Handling InstructionsFor sustained reagent performance and accuracy, it is essential to store the MAGLUMI ENA Screen (CLIA) between 2C and 8C. Proper refrigeration maintains reagent integrity and extends its shelf life. Adhering to the manufacturer's storage guidelines guarantees consistent and reliable assay performance, safeguarding valuable diagnostic results for both routine and research purposes.
FAQ's of MAGLUMI ENA Screen (CLIA):
Q: How does the MAGLUMI ENA Screen (CLIA) work in laboratory settings?
A: MAGLUMI ENA Screen (CLIA) utilizes chemiluminescence immunoassay technology to detect ENA antibodies in human serum or plasma. The reagent is processed on MAGLUMI CLIA analyzers, enabling precise and automated analysis for clinical laboratories.
Q: What are the recommended storage conditions for the MAGLUMI ENA Screen (CLIA)?
A: The reagent should be stored in a refrigerator at a temperature between 2C and 8C. Proper storage within this range ensures product stability and maintains test accuracy throughout its shelf life.
Q: When should laboratories use the MAGLUMI ENA Screen (CLIA)?
A: This reagent is ideal for use during the diagnosis and monitoring of autoimmune disorders where detection of ENA antibodies is required. It is specifically valuable during initial screening and follow-up testing phases.
Q: Where can the MAGLUMI ENA Screen (CLIA) be applied?
A: MAGLUMI ENA Screen (CLIA) is designed for use exclusively in laboratory settings equipped with MAGLUMI CLIA analyzers. It serves hospitals, clinics, research centers, and diagnostic laboratories.
Q: What is the process for performing tests with MAGLUMI ENA Screen (CLIA)?
A: To conduct tests, users load the reagent onto a compatible MAGLUMI CLIA analyzer, which automates the immunoassay process. The platform handles sample preparation, incubation, detection, and result calculation efficiently.
Q: What are the benefits of using the MAGLUMI ENA Screen (CLIA)?
A: Users benefit from high sensitivity, specificity, and quick turnaround times. The reagent offers reliable detection of autoantibodies essential for accurate autoimmune disease diagnosis, enhancing clinical decision-making for patient care.